Aura Biosciences, Inc. Earnings Per Share (Basic)
Aura Biosciences, Inc. (AURA) reported Earnings Per Share (Basic) of -$0.48 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-11
- Aura Biosciences, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.48.
- Aura Biosciences, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.50.
- Aura Biosciences, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$0.38.
- Aura Biosciences, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.40.
- Aura Biosciences, Inc. earnings per share, basic for fiscal 2025 was -$1.76.
- Aura Biosciences, Inc. earnings per share, basic for fiscal 2024 was -$1.75.
- Aura Biosciences, Inc. earnings per share, basic for fiscal 2023 was -$1.93.
- Aura Biosciences, Inc. earnings per share, basic for fiscal 2022 was -$1.96.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.48 10-Q · filed 2026-08-11 | -$0.98 10-Q · filed 2026-08-11 | -$1.37 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$1.77 derived: net income ÷ weighted average shares · filed 2026-08-11 |
| 2026-03-31 | -$0.50 10-Q · filed 2026-05-11 | -$0.88 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$1.28 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$1.74 derived: net income ÷ weighted average shares · filed 2026-08-11 |
| 2025-12-31 | -$0.38 derived: net income ÷ weighted average shares · filed 2026-03-30 | -$0.78 derived: net income ÷ weighted average shares · filed 2026-03-30 | -$1.24 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$1.76 10-K · filed 2026-03-30 |
| 2025-09-30 | -$0.40 10-Q · filed 2025-11-13 | -$0.86 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$1.39 10-Q · filed 2025-11-13 | -$1.90 derived: net income ÷ weighted average shares · filed 2026-08-11 |
| 2025-06-30 | -$0.47 10-Q · filed 2026-08-11 | -$1.01 10-Q · filed 2026-08-11 | -$1.52 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$1.95 derived: net income ÷ weighted average shares · filed 2026-08-11 |
| 2025-03-31 | -$0.55 10-Q · filed 2026-05-11 | -$1.07 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$1.49 derived: net income ÷ weighted average shares · filed 2026-08-11 | -$1.90 derived: net income ÷ weighted average shares · filed 2026-08-11 |
| 2024-12-31 | -$0.52 derived: net income ÷ weighted average shares · filed 2026-03-30 | -$0.94 derived: net income ÷ weighted average shares · filed 2026-03-30 | -$1.35 derived: net income ÷ weighted average shares · filed 2026-03-30 | -$1.75 10-K · filed 2026-03-30 |
| 2024-09-30 | -$0.42 10-Q · filed 2025-11-13 | -$0.83 derived: net income ÷ weighted average shares · filed 2025-11-13 | -$1.23 10-Q · filed 2025-11-13 | -$1.72 derived: net income ÷ weighted average shares · filed 2025-11-13 |
| 2024-06-30 | -$0.41 10-Q · filed 2025-08-13 | -$0.81 10-Q · filed 2025-08-13 | -$1.30 derived: net income ÷ weighted average shares · filed 2025-11-13 | -$1.77 derived: net income ÷ weighted average shares · filed 2025-11-13 |
| 2024-03-31 | -$0.40 10-Q · filed 2025-05-15 | -$0.89 derived: net income ÷ weighted average shares · filed 2025-11-13 | -$1.37 derived: net income ÷ weighted average shares · filed 2025-11-13 | -$1.85 derived: net income ÷ weighted average shares · filed 2025-11-13 |
| 2023-12-31 | -$0.50 derived: net income ÷ weighted average shares · filed 2025-03-24 | -$0.98 derived: net income ÷ weighted average shares · filed 2025-03-24 | -$1.47 derived: net income ÷ weighted average shares · filed 2025-03-24 | -$1.93 10-K · filed 2025-03-24 |
| 2023-09-30 | -$0.48 10-Q · filed 2024-11-12 | -$0.97 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$1.43 10-Q · filed 2024-11-12 | -$1.94 derived: net income ÷ weighted average shares · filed 2024-11-12 |
| 2023-06-30 | -$0.48 10-Q · filed 2024-08-08 | -$0.95 10-Q · filed 2024-08-08 | -$1.46 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$1.99 derived: net income ÷ weighted average shares · filed 2024-11-12 |
| 2023-03-31 | -$0.46 10-Q · filed 2024-05-09 | -$0.98 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$1.51 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$1.98 derived: net income ÷ weighted average shares · filed 2024-11-12 |
| 2022-12-31 | -$0.52 derived: net income ÷ weighted average shares · filed 2024-03-27 | -$1.06 derived: net income ÷ weighted average shares · filed 2024-03-27 | -$1.52 derived: net income ÷ weighted average shares · filed 2024-03-27 | -$1.96 10-K · filed 2024-03-27 |
| 2022-09-30 | -$0.54 10-Q · filed 2023-11-09 | -$1.00 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$1.44 10-Q · filed 2023-11-09 | -$2.01 derived: net income ÷ weighted average shares · filed 2023-11-09 |
| 2022-06-30 | -$0.46 10-Q · filed 2023-08-09 | -$0.90 10-Q · filed 2023-08-09 | -$1.46 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$2.39 derived: net income ÷ weighted average shares · filed 2023-11-09 |
| 2022-03-31 | -$0.44 10-Q · filed 2023-05-11 | -$1.01 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$2.04 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$3.41 derived: net income ÷ weighted average shares · filed 2023-11-09 |
| 2021-12-31 | -$0.60 derived: net income ÷ weighted average shares · filed 2023-03-15 | -$2.07 derived: net income ÷ weighted average shares · filed 2023-03-15 | -$4.35 derived: net income ÷ weighted average shares · filed 2023-03-15 | -$8.95 10-K · filed 2023-03-15 |
| 2021-09-30 | -$28.33 10-Q · filed 2022-11-10 | -$40.25 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$77.93 10-Q · filed 2022-11-10 | |
| 2021-06-30 | -$28.53 10-Q · filed 2022-08-11 | -$49.49 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B |